The global arthroscopy procedures and products market is expected to reach a valuation of USD 6,860.8 million in 2023.
Driven by increasing application in sports medicine and the rising prevalence of osteoarthritis (OA) in the geriatric population, the market revenue is poised to expand at over 6.2% CAGR during the forecast period from 2023 to 2033.
Growth across North America and Europe remains high owing to the increasing preference for arthroscopic surgeries among the geriatric population, especially across the United States and Germany. North America and Europe collectively account for over 77% of the global revenue share.
Drivers:
Restraints:
Opportunities:
Trends:
| Attribute | Details |
|---|---|
| Global Arthroscopy Procedure and Products Market Size (2023) | USD 6,860.8 million |
| Predicted Sales (2033) | USD 13,265.6 million |
| Global Market Growth Rate (2023 to 2033) | 6.2% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Increasing application in sports medicine, the rising geriatric population, and the increasing prevalence of osteoarthritis across the globe are some of the factors driving the global arthroscopy procedures and products market.
The rapid adoption of arthroscopy devices to examine the bone joints for osteoarthritis, rheumatoid arthritis, bone tumor, and other knee injuries have improved the demand. Between 2018 and 2022, the market was forecast to register a CAGR of over 4.9%.
As per FMI's analysis, the market's revenue is slated to increase at a stellar pace of over 6.2% CAGR during the forecast period of 2023 and 2033. With a rising preference for minimally invasive surgeries for knee replacement and other injuries, the demand for arthroscopy procedures is increasing.
Growing geriatric population across the United States, Germany, China, India, and Japan, combined with the rising cases of rheumatoid arthritis and osteoarthritis, market growth is anticipated to bolster over the coming years.
As per the survey of Harvard Health Publishing, every year, an estimated 750,000 arthroscopic knee surgeries are performed across the United States, costing almost USD 4 billion. Over 30 million Americans were diagnosed with osteoarthritis in 2022, among which 10% were men over 60.
With increasing cases of osteoarthritis, patients opt for arthroscopy instead of arthroplasty as a minimally invasive procedure. This, in turn, will improve the sales of arthroscopy procedures and products market.
As per Future Market Insights, degenerative knee disease is gaining prevalence among the geriatric population, aiding the demand for knee arthroscopy. Owing to the rising preference for arthroscopic knee surgeries, the arthroscopic knee segment will contribute to more than half of the global market sales.
The market is anticipated to post substantial gains in the future, as the demand for minimally invasive surgeries is rising with the growing incidence of osteoarthritis among the geriatric population.
Based on the aforementioned factors, the market is anticipated to surpass a valuation of approx. USD 6,860.8 million in 2023.
The rising prevalence of osteoarthritis (OA) among the geriatric population and increasing incidence of joint-related injury or sports injury have augmented the number of arthroscopic procedures performed globally.
As per the estimated figure of OA Prevalence and Burden, around 78 million people are projected to be diagnosed with some form of arthritis, among which 32.5 million adults in the United States will have severe osteoarthritis.
As per data from Stanford Children's Health, around 30 million children across the United States participate in some form of organized sports, resulting in 3.5 million injuries every year. More than 775,000 children are treated for recreational and traumatic sports injuries every year.
With such rising statistics of degenerative diseases and injuries, government across the globe has increased funding & favorable policies to support the need for rehabilitation worldwide.
For instance, World Health Organization (WHO) launched the Rehabilitation 2030 initiative in 2017 to draw attention to the profound unmet need for rehabilitation worldwide and highlight the importance of strengthening health systems to provide rehabilitation.
WHO has also developed a 'Package of Interventions for Rehabilitation, which comprises fractures in the extremities, osteoarthritis, rheumatoid arthritis, and low back pain.
It includes a list of priority evidence-based interventions for rehabilitation and the resources required to deliver them safely and effectively.
Such favorable policies will aid the growth of the global arthroscopy procedures and products market over the coming years.
Principal Consultant
High costs associated with the treatment of musculoskeletal diseases and lack of awareness regarding effective treatment therapies are some of the factors which are likely to restrain the market growth in the near future.
Despite being a widely used procedure for curing extremely debilitating diseases, such as osteoarthritis, the global arthroscopy procedures & products market is facing some challenges, such as an economic slowdown that is preventing the market from growing.
Some of the other growth restraining factors are the availability of alternative procedures such as knee replacement surgery & others and growing awareness for some non-surgical treatment methods.
Also, the risk of edema due to irrigation fluids will also hamper the market demand over the coming years. Other risks, such as thrombophlebitis, artery damage, and infection inside the knee joints and ligaments, will also restrict the market growth.
The United States is anticipated to play a crucial role within the North American region, with an estimated market share of 31.0% in 2023. Driven by an increasing number of ambulatory surgical centers, advancement in technology, expansion of healthcare infrastructure, and extensive usage of arthroscopic instruments used in knee, hips, & shoulder procedure are some of the factors boosting the growth across the United States
Future Market Insights estimates the United States is likely to be the most lucrative market for arthroscopy procedures and products over the coming years.
Owing to increasing knee arthroscopic procedures, the United States market is expected to register substantial gains during the forecast period.
According to the Centres for Disease Control and Prevention (CDC), with the rising geriatric population, the prevalence of osteoarthritis across the United States has been increasing. For instance, by 2040, around 34.6 million people are projected to suffer from osteoarthritis.
With the rising burden of this disease, due to cost-effective surgery and non-invasive nature, preference for knee arthroscopy will witness a surge over the coming years as compared to knee replacement surgery.
Arthroscopic knee surgery has been the most common procedure for degenerative knee diseases across the United States
Injuries caused due to sports and recreational activities are increasing the cases of knee, shoulder, and hip arthroscopic surgeries across the United States
As per Insurance Information Institute, in 2019, around 468,000 injuries were recorded due to sports and recreational activities. Among these, 404,000 injuries were reported due to basketball, and 292,000 were recorded due to football.
With the rising number of incidents and increasing cases of degenerative diseases across the United States, the growth of arthroscopy procedures & products will bolster over the forecast period.
The United Kingdom is estimated to hold a market share of 6.0% in 2023, highlighting its continued contribution to the arthroscopy procedures and products industry.
This growth is attributed to the technological advancements in the healthcare industry and the rising geriatric population across the country.
Approximately 1 in 5 adults above the age of 45 years across the United Kingdom have osteoarthritis of the knee, and 1 in 9 adults have osteoarthritis of the hip, states Arthritis Research UK report.
With the rising incidence of osteoarthritis among the elderly population, there has been a noticeable surge in the preference for arthroscopic surgeries across the United Kingdom.
Additionally, technological advancement in arthroscopic instruments is the factor anticipated to fuel demand across the country.
China is projected to record a CAGR of 9.3% in 2023, solidifying its position as a prominent player in the arthroscopy procedures and products industry. China is estimated to be the most lucrative market in East Asia, owing to the increasing geriatric population and rising prevalence of knee arthroscopic procedures across the country.
The burden for knee osteoarthritis Chinese elderly estimated that around 4,149,628 people were diagnosed with knee osteoarthritis, and among that, almost 3.9% of the population needed a knee arthroscopy.
The Southwest region in China had the highest rate of people suffering from knee osteoarthritis (OA) in 2018. The total number of patients recorded for knee OA in China was 1470994 in men and 2678624 in women.
With the rising burden of knee OA, healthcare professionals, and the government have initiated awareness programs, and healthcare companies have increased the funding for the development of advanced arthroscopy instruments.
Rising preference for minimally invasive surgeries among the elderly has improved the adoption of knee arthroscopy, resulting in higher demand for arthroscopy procedures and products market.
As per FMI, the market across China is projected to exhibit an above-average CAGR in terms of value during the forecast period of 2023 and 2033.
Germany is expected to emerge as a significant market in Europe, with an estimated market share of 10.5% in 2023. A number of orthopedic injuries have seen a sharp fall during the FQ-20 across Germany due to the global shutdown. However, the prevalence of selected musculoskeletal conditions grew 2x in 2022 over 2000.
Around 17.8% of adults across Germany are diagnosed with osteoarthritis, whereby prevalence among women is higher by 7.9% than among men, says Journal of Health Monitoring, Germany.
Along with the rising knee degenerative diseases across the country, the expansion of the healthcare industry is another factor aiding the market growth.
High investment by healthcare companies in the development of advanced products & instruments will accelerate the demand in the coming years.
Due to the non-invasive nature of the surgery, patients with severe osteoarthritis prefer arthroscopy procedure for knee, hip, or shoulder replacement. However, the high cost of the procedure as compared to standard surgery might restrain the market growth.
As per the data by Joint Surgeons in Germany, a minimally invasive complex knee arthroscopy procedure costs USD 8769.15. Hence, the average cost of an arthroscopic procedure is quite pricey, which might lead people to not opt for the surgery, limiting the market growth.
In 2023, Japan is projected to exhibit a compound annual growth rate (CAGR) of 3.6%, continuing to make significant contributions to the global arthroscopy procedures and products industry. The country's aging population, coupled with the high prevalence of orthopedic disorders, drives the demand for arthroscopy procedures. Japan has a well-developed healthcare system that emphasizes technological advancements and patient-centric care. The adoption of minimally invasive techniques, including arthroscopy, is increasing due to their benefits, such as faster recovery times and reduced hospital stays. Additionally, the presence of leading medical device manufacturers and ongoing research activities contribute to Japan's continued growth and market share in the arthroscopy industry.
With an anticipated CAGR of 6.0% in 2023, Australia maintains an active presence and contributes to the arthroscopy procedures and products industry. The country's healthcare sector is characterized by advanced medical facilities, a skilled workforce, and a focus on delivering high-quality patient care. Australia's active participation in sports and outdoor activities leads to a higher incidence of orthopedic injuries, increasing the demand for arthroscopy procedures. Moreover, healthcare awareness and access to specialized healthcare services contribute to the growth of the arthroscopy market in Australia. Continued investments in healthcare infrastructure, along with research and development initiatives, further strengthen Australia's position in the industry.
In 2023, India is expected to showcase a CAGR of 8.9%, reflecting its growing significance in the arthroscopy procedures and products industry. The country's large patient pool, rising healthcare spending, and increasing awareness about advanced medical technologies contribute to the expanding demand for arthroscopy procedures.
India has seen a surge in orthopedic surgeries driven by factors such as an aging population, a rising number of sports injuries, and lifestyle changes. The government's initiatives to improve healthcare infrastructure, promote medical tourism, and enhance access to quality healthcare further support the growth of the arthroscopy market in India.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Arthroscopic implants capture a significant market share of 65.45% in the arthroscopy procedure and products industry. Their dominance is driven by technological advancements, the rising prevalence of orthopedic disorders, the minimally invasive nature of procedures, surgeon preference and expertise, and patient demand for improved quality of life.
These implants offer effective solutions for joint repair, enhancing patient outcomes and accelerating recovery. With continuous innovation and growing demand, arthroscopic implants are revolutionizing the field of orthopedic care and shaping the future of joint repair procedures.
Due to its non-invasive nature, the elder, as well as the younger population, opt for arthroscopy instead of replacement surgery. Demand for arthroscopic implants is on the rise owing to the availability of smart & customized implants, widening the adoption of arthroscopic procedures.
Centers for Disease Control & Prevention estimates around 54.4 million adults in the United States have some kind of arthritis, among which 32.5 million adults are diagnosed with osteoarthritis.
By 2040, around 78 million people are projected to have some kind of arthritis, with osteoarthritis as the most common form of arthritis.
With the rising prevalence of this disease and the increase in clinical evidence related to safety and efficacy, the growth of the arthroscopic implant segment is anticipated to boost over the coming years.
Economic benefits and rising disposable income across the globe will also aid the growth of arthroscopic implants over the coming years.
On the basis of procedure type, the market is segmented into shoulder arthroscopy, hip arthroscopy, knee arthroscopy, elbow arthroscopy, small joints arthroscopy, and others.
Owing to the rising prevalence of degenerative knee diseases among the geriatric population across the globe, surgeons carry out over 600,000 knee replacements every year across the United States, reports the American Academy of Orthopedic Surgeons.
Due to its non-invasive nature and low cost as compared to open surgical methods, the popularity of knee arthroscopy has been soaring among the geriatric population. With increasing cases of osteoarthritis, annually across the globe, around 4 million knee arthroscopic surgeries are carried out to avoid knee replacement surgeries.
Other factors that are increasing the popularity of knee arthroscopy are surging cases of musculoskeletal disorders among the elderly, along with rising incidences of rheumatoid arthritis and osteoarthritis.
As per the Future Market Insights estimates, knee arthroscopy is anticipated to account for more than 50% of the global market share in the upcoming decade.
In the highly competitive arthroscopy procedure and products industry, key players are engaged in a relentless pursuit of innovation and market dominance. These companies are at the forefront of driving advancements in arthroscopic technologies and products, investing heavily in research and development. By introducing cutting-edge solutions and continuously improving their offerings, they maintain their stronghold in the market.
However, navigating the industry landscape comes with its challenges. Regulatory compliance and stringent quality standards pose significant hurdles for companies in this field. To stay ahead, key players must differentiate themselves through unique product offerings and strategic partnerships. The fierce competition necessitates constant adaptation and the ability to provide cost-effective solutions, particularly in the face of rising healthcare costs and reimbursement uncertainties.
Looking toward the future, digitalization and personalized care will play pivotal roles in shaping the industry. Companies are embracing telemedicine, remote monitoring, and data analytics to enhance patient outcomes and improve efficiency. Customized solutions, personalized implants, and patient-specific treatment plans are gaining traction, enabling companies to offer a higher level of individualized care and stand out in the competitive landscape.
Leading healthcare companies are engaging in research & development activities to focus on the development of orthopedic surgical treatments, leveraging their core expertise to strengthen their global foothold.
Long-term collaborations with top players and product launches are on the card for future expansion growth prospects among key players. Targeted mergers and partnerships with arthroscopy manufacturing business units will be the key strategy of market players to maintain their leadership in the industry.
Scaling Strategies for Manufacturers/Service Providers in the Arthroscopy Procedure and Products Market
Research and Development
Invest in extensive research and development activities to innovate and develop advanced arthroscopic products and technologies. Continuously improve existing products and explore new avenues for growth.
Strategic Partnerships
Form strategic partnerships with healthcare institutions, surgeons, and medical professionals to expand market reach and access new customer segments. Collaborate with research organizations to leverage their expertise and stay at the forefront of technological advancements.
Market Expansion
Identify and tap into emerging markets with high growth potential. Establish a strong distribution network and local presence to cater to the demands of diverse regions effectively. Develop tailored marketing and sales strategies to target specific customer segments and adapt to regional preferences.
Customer-Centric Approach
Place a strong emphasis on understanding customer needs and preferences. Provide personalized solutions and exceptional customer service to build long-term relationships. Continuously gather customer feedback to improve products and address any gaps in the market.
Operational Efficiency
Streamline internal processes and operations to enhance efficiency and reduce costs. Implement lean manufacturing practices, optimize supply chain management, and leverage automation and digital technologies to improve productivity.
Training and Education
Invest in training programs for healthcare professionals to ensure proper usage and application of arthroscopic products. Conduct educational workshops and seminars to enhance knowledge and skill levels. Establish strong educational partnerships to promote the use of arthroscopy procedures.
Regulatory Compliance
Stay updated with changing regulations and compliance standards in the healthcare industry. Ensure strict adherence to quality control and safety measures to build trust and credibility among customers.
Continuous Improvement
Foster a culture of continuous improvement within the organization. Encourage employee involvement in innovation and process optimization. Regularly assess market trends and competitor activities to stay ahead of the curve.
Technological Integration
Embrace technological advancements such as robotics, artificial intelligence, and digitalization to enhance product capabilities and improve patient outcomes. Explore opportunities in telemedicine, remote monitoring, and data analytics to provide value-added services.
Market Research and Analysis
Conduct thorough market research and analysis to identify market gaps, emerging trends, and unmet needs. Stay informed about industry dynamics, competitive landscape, and customer preferences to make informed business decisions.
Key Developments in the Market:
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | USD Million for Value |
| Key Countries Covered | United States, Canada, Germany, United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa |
| Key Segments Covered | Product Type, Procedure type, and Region |
| Key Companies Profiled | Arthrex Inc.; CONMED Corporation; Johnson & Johnson; KARL STORZ GmbH & Co. KG; Olympus Corporation; Richard Wolf GmbH; Stryker Corporation; Others |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The arthroscopy procedure and products market is expected to surpass a valuation of USD 6,860.8 million in 2023
The arthroscopy procedure and products market witnessed growth at above 4.9% CAGR between 2018 and 2022.
The rising prevalence of degenerative disease among the geriatric population, the soaring popularity of knee arthroscopy, and the increasing incidence of sports-related injuries will improve
Arthrex, Inc., CONMED Corporation, Johnson & Johnson, KARL STORZ GmbH & Co. KG, and Olympus Corporation are the top players leading the arthroscopy Procedure and products market.
The market in Europe and North America, collectively, will account for over 78% revenue share of the global arthroscopy procedure & products market.
Top countries in terms of arthroscopy Procedure and products sales are the United States, Germany, India, China, and the United Kingdom
The market is valued at USD 6,860.8 million In 2023.
The market is anticipated to experience a 6.2% CAGR from 2023 to 2033.
The market is likely to reach USD 13,265.6 million in 2033.
In 2023, Japan is projected to exhibit a CAGR of 3.6%.
Richard Wolf GmbH, Stryker Corporation, and, Arthrex Inc. are the leading industry players.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Arthroscopes and Visualization Systems 5.2. Arthroscopic Resection Systems 5.3. Arthroscopic Fluid Management Systems 5.4. Arthroscopic Implants 5.4.1. Knee Implants 5.4.2. Shoulder Implants 5.4.3. Hip Implants 5.4.4. Other Implants 5.5. Arthroscopy Radiofrequency (RF) Systems 5.6. Arthroscopic Drills and Fixation Systems 5.7. Other Arthroscopy Instruments and Accessories 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Procedure Type 6.1. Shoulder Arthroscopy 6.2. Hip Arthroscopy 6.3. Knee Arthroscopy 6.4. Elbow Arthroscopy 6.5. Small Joints Arthroscopy 6.6. Others 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. North America 7.2. Latin America 7.3. Europe 7.4. South Asia 7.5. East Asia 7.6. Oceania 7.7. Middle East and Africa (MEA) 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Key Countries Market Analysis 16. Market Structure Analysis 17. Competition Analysis 17.1. Arthrex Inc. 17.2. CONMED Corporation 17.3. Johnson & Johnson 17.4. KARL STORZ GmbH & Co. KG 17.5. Olympus Corporation 17.6. Richard Wolf GmbH 17.7. Stryker Corporation 17.8. Smith & Nephew plc 17.9. Zimmer Biomet Holdings 17.10. Medtronic plc 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Arthroscopy Procedure and Products Market
